Tech Company Financing Transactions

Guardant Health Funding Round

Lightspeed Venture Partners, Formation 8 and Khosla Ventures participated in a $50 million Series C capital raise for Guardant Health. The round was announced by the company on 2/3/2015.

Transaction Overview

Company Name
Guardant Health
Announced On
2/3/2015
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series C
Investors

Lightspeed Venture Partners (Lead Investor) (Christopher Schaepe)

Formation 8

Khosla Ventures (Samir Kaul)

Sequoia Capital (Warren Hogarth)

Proceeds Purpose
The company plans to use the funds to expand the availability of Guardant360, and for continued investment in the acceleration of its product roadmap to more rapidly achieve the company's vision of transforming cancer into a manageable disease.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
505 Penobscot Dr.
Redwood City, CA 94063
USA
Phone
(855) 698-8887
Website
www.guardanthealth.com
Email Address
[email protected]
Overview
Guardant360 is the only biopsy-free tumor sequencing test that tracks tumor genomics in real-time.
Profile
Guardant Health LinkedIn Company Profile
Social Media
Guardant Health Company Twitter Account
Company News
Guardant Health News
Facebook
Guardant Health on Facebook
YouTube
Guardant Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Helmy Eltoukhy
  Helmy Eltoukhy LinkedIn Profile  Helmy Eltoukhy Twitter Account  Helmy Eltoukhy News  Helmy Eltoukhy on Facebook
Chief Financial Officer
Derek Bertocci
  Derek Bertocci LinkedIn Profile  Derek Bertocci Twitter Account  Derek Bertocci News  Derek Bertocci on Facebook
President
AmirAli Talasaz
  AmirAli Talasaz LinkedIn Profile  AmirAli Talasaz Twitter Account  AmirAli Talasaz News  AmirAli Talasaz on Facebook
Vice President
Darya Chudova
  Darya Chudova LinkedIn Profile  Darya Chudova Twitter Account  Darya Chudova News  Darya Chudova on Facebook
VP - Bus. Development
Daniel Simon
  Daniel Simon LinkedIn Profile  Daniel Simon Twitter Account  Daniel Simon News  Daniel Simon on Facebook
VP - General Counsel
Michael Wiley
  Michael Wiley LinkedIn Profile  Michael Wiley Twitter Account  Michael Wiley News  Michael Wiley on Facebook
VP - Operations
Andrew Ament
  Andrew Ament LinkedIn Profile  Andrew Ament Twitter Account  Andrew Ament News  Andrew Ament on Facebook
VP - Regulatory Affairs
Morteza Minaee
  Morteza Minaee LinkedIn Profile  Morteza Minaee Twitter Account  Morteza Minaee News  Morteza Minaee on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/3/2015: Primadesk venture capital transaction
Next: 2/3/2015: eRelevance venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.